Medizinische Tipps Online

Medizinische Tipps Online

  •  

CTI receives U.S. Patent Allowance for GlycoPolymer technology

January 07, 2020

The Pain therapeutic area encompasses any disease where pain is a major symptom. The unmet medical need for patients in pain is enormous, with the greatest need being for a more effective therapy that is well tolerated and safe over a long period of time. Within the pain marketplace, current pain treatments are unsatisfactory; overall efficacy is poor (typically 1-2 point reductions on a 10 point scale) and satisfactory to less than 50% of patients. Whilst treatments, such as opioids and non-ste...

FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia

January 06, 2020

"Today's approval of ERWINAZE highlights EUSA's ongoing commitment to the oncology field, and the treatment of patients affected by orphan diseases.  We are grateful to our partners at the UK Health Protection Agency, our investigators and employees, and to the Food and Drug Administration for their dedication to this effort and for helping us make ERWINAZE available to the hundreds of patients who can benefit from it each year," said Dr. Tim Corn, EUSA Pharma's Chief Medical Offi...

Wake Forest Baptist, VA partner to advance treatment of PTSD and TBI

January 05, 2020

In addition to assessing functional brain networks with MEG, the investigators will examine the structure of white matter pathways of the brain to see whether the physical connections between brain areas may also differ among those with and without the disorder. The major goal of the study is to define biomarkers of PTSD and TBI so that doctors will have a way to very quickly identify patients with PTSD and get them treatment without delay, as well as to chart their progress in response to treat...

Senator Klein opens new Cognitive Neurophysiology Laboratory at Albert Einstein College of Medicine

January 04, 2020

"The construction and outfitting of the Cognitive Neurophysiology Lab was greatly assisted by the New York State capital budget funding secured by Senator Klein," said John Foxe, Ph.D., director of research at Einstein's Children's Evaluation and Rehabilitation Center and professor of pediatrics and of neuroscience. "With this support, I was able to return to Einstein to lead an outstanding team of researchers and clinicians searching for the causes of and treatments for intellect...

Medgenics signs $7 million agreement to develop the Biopump technology for Factor VIII

January 03, 2020

No single drug is effective for every patient, and there is great variability in toxicity and price, ranging from about $400 to $15,000 a year. Bridges says the next major advance needed in the treatment of RA is not additional drugs, but, rather, a dramatic improvement in the efficiency and cost-effectiveness of the use of current drugs for individual patients with RA."TETRAD will fill a critical need by aligning and uniting the efforts of many organizations with the common goal of improvi...